SCHEMBL30488135

SCHEMBL30488135

COC(=O)Cc1cccc(NC(N)=S)c1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
CYP1A2 P05177 1/20 0.51
SLC7A5 Q01650 1/20 0.51
KMT2A Q03164 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 1/20 0.49
HPGD P15428 1/20 0.48
GAA P10253 2/20 0.47
GFER P55789 1/20 0.47
USP2 O75604 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.44
MAPT P10636 1/20 0.44
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25269919 1.00 ALDH1A1 (0.58) ALDH1A1CYP1A2SLC7A5KMT2ASMN1; SMN2
SCHEMBL8773972 0.88 SLC7A5 (0.54) ALDH1A1SLC7A5KMT2ASMN1; SMN2LMNA
SCHEMBL4523190 0.86 SIRT2 (0.60) ALDH1A1CYP1A2KMT2ALMNAHPGD
SCHEMBL17653723 0.83 SLC7A5 (0.55) ALDH1A1CYP1A2SLC7A5KMT2ASMN1; SMN2
SCHEMBL30489996 0.83 SLC7A5 (0.55) ALDH1A1CYP1A2SLC7A5KMT2ASMN1; SMN2
SCHEMBL4515437 0.83 HPSE (0.57) ALDH1A1CYP1A2KMT2ALMNAGAA
SCHEMBL17869670 0.81 SLC7A5 (0.56) ALDH1A1SLC7A5KMT2ASMN1; SMN2LMNA
SCHEMBL25230746 0.81 ALDH1A1 (0.62) ALDH1A1KMT2ASMN1; SMN2LMNAHPGD
SCHEMBL11628350 0.81 SLC7A5 (0.52) ALDH1A1SLC7A5KMT2ASMN1; SMN2LMNA
SCHEMBL8686054 0.80 SLC7A5 (0.59) ALDH1A1SLC7A5KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709725-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2026-03-18 EP disclosed
WO-2024233642-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2024-11-14 WO disclosed
WO-2023107630-A2 AMINO ALCOHOL COMPOUNDS AND USES THEREOF Kineta, Inc. (US) 2023-06-15 WO disclosed